Bordet R

References (10)

Title : Functional connectivity and cognitive changes after donepezil treatment in healthy participants - Peran_2021_Psychopharmacology.(Berl)__
Author(s) : Peran P , Salabert AS , Dondaine T , Leclerc X , Gros-Dagnac H , Ranjeva JP , Lopes R , Lanteaume L , Blin O , Thalamas C , Bordet R , Payoux P
Ref : Psychopharmacology (Berl) , : , 2021
Abstract :
PubMedSearch : Peran_2021_Psychopharmacology.(Berl)__
PubMedID: 34370064

Title : Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus) - Rahman_2017_PLoS.One_12_e0184822
Author(s) : Rahman A , Lamberty Y , Schenker E , Cella M , Languille S , Bordet R , Richardson J , Pifferi F , Aujard F
Ref : PLoS ONE , 12 :e0184822 , 2017
Abstract :
PubMedSearch : Rahman_2017_PLoS.One_12_e0184822
PubMedID: 28922421

Title : Early development of symptomatic drugs in AD: a systematic review of the use of biomarkers - Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_
Author(s) : Deguil J , Ravasi L , Lamberty Y , Auffret A , Payoux P , Leroy C , Derambure P , Bordet R
Ref : CNS Neurol Disord Drug Targets , : , 2016
Abstract :
PubMedSearch : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_
PubMedID: 27189465

Title : Translational challenge models in support of efficacy studies: effect of cerebral hypoxia on cognitive performances in rodents - Deguil_2016_CNS.Neurol.Disord.Drug.Targets_1_
Author(s) : Deguil J , Ravasi L , Lanteaume L , Lamberty Y , Bordet R
Ref : CNS Neurol Disord Drug Targets , : , 2016
Abstract :
PubMedSearch : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_1_
PubMedID: 27189464

Title : Cholinergic modulation of stimulus-driven attentional capture - Boucart_2015_Behav.Brain.Res_283_47
Author(s) : Boucart M , Michael GA , Bubicco G , Ponchel A , Waucquier N , Deplanque D , Deguil J , Bordet R
Ref : Behavioural Brain Research , 283 :47 , 2015
Abstract :
PubMedSearch : Boucart_2015_Behav.Brain.Res_283_47
PubMedID: 25619685

Title : New pharmacological options for treating advanced Parkinson's disease - Devos_2013_Clin.Ther_35_1640
Author(s) : Devos D , Moreau C , Dujardin K , Cabantchik I , Defebvre L , Bordet R
Ref : Clin Ther , 35 :1640 , 2013
Abstract :
PubMedSearch : Devos_2013_Clin.Ther_35_1640
PubMedID: 24011636

Title : Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients - Babiloni_2013_Clin.Neurophysiol_124_837
Author(s) : Babiloni C , Del Percio C , Bordet R , Bourriez JL , Bentivoglio M , Payoux P , Derambure P , Dix S , Infarinato F , Lizio R , Triggiani AI , Richardson JC , Rossini PM
Ref : Clin Neurophysiol , 124 :837 , 2013
Abstract :
PubMedSearch : Babiloni_2013_Clin.Neurophysiol_124_837
PubMedID: 23098644

Title : [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease] - Devos_2010_Rev.Neurol.(Paris)_166_168
Author(s) : Devos D , Bordet R , Defebvre L
Ref : Rev Neurol (Paris) , 166 :168 , 2010
Abstract :
PubMedSearch : Devos_2010_Rev.Neurol.(Paris)_166_168
PubMedID: 19811797

Title : Importance of circadian rhythmicity in the cholinergic treatment of Alzheimer's disease: focus on galantamine* - Nieoullon_2008_Curr.Med.Res.Opin_24_3357
Author(s) : Nieoullon A , Bentue-Ferrer D , Bordet R , Tsolaki M , Forstl H
Ref : Curr Med Res Opin , 24 :3357 , 2008
Abstract :
PubMedSearch : Nieoullon_2008_Curr.Med.Res.Opin_24_3357
PubMedID: 19032118

Title : [Pharmacology of Alzheimer's disease: where do we go from here?] - Sellal_2005_Therapie_60_89
Author(s) : Sellal F , Nieoullon A , Michel G , Michel BF , Lacomblez L , Geerts H , Delini-Stula A , Bentue-Ferrer D , Bordet R , Allain H
Ref : Therapie , 60 :89 , 2005
Abstract :
PubMedSearch : Sellal_2005_Therapie_60_89
PubMedID: 15969312